Sorry, you need to enable JavaScript to visit this website.
    Pfizer Press releaseFinancialFinanceMedicinesResearchVaccines

Pfizer Invites Public to Register for Webcast of Pfizer Near-Term Launches + High-Value Pipeline Day

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) invites investors and the general public to access a live video webcast of its Near-Term Launches + High-Value Pipeline Day on Monday, December 12, 2022 from 1:00 p.m. EST to 6:00 p.m. EST, with an approximately 30 minute break at the midpoint. Pfizer business executives and scientific leadership will provide updates on the company’s potential near-term product launches and key high-value pipeline programs, both of which are expected to be primary growth drivers for Pfizer’s 2030 revenues and beyond.

To access the live webcast and presentation slides, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today. Participants are advised to register in advance.

Participants will also have an opportunity to submit questions via the webcast and selected questions will be asked during the live Q&A sessions with leadership.

Participants who are unable to join the webcast from a computer or mobile device can dial either (800) 456-4352 in the United States and Canada or (785) 424-1086 outside of the United States and Canada. The passcode is “12304”. This audio line is a “listen only” experience and questions cannot be submitted through the audio line.

The transcript and webcast replay will be made available on our web site at www.pfizer.com/investors within 24 hours after the end of the live webcast and will be accessible for at least 90 days.

About Pfizer: Breakthroughs That Change Patients’ Lives

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.

Disclosure Notice:The webcast may include forward-looking statements about, among other things, our anticipated future operating and financial performance; reorganizations; business plans, strategy and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, launches, clinical trial results and other developing data, revenue contribution and projections, growth, performance, timing of exclusivity and potential benefits; strategic reviews, capital allocation objectives, dividends and share repurchases; plans for and prospects of our acquisitions, dispositions and other business development activities; our ability to successfully capitalize on growth opportunities and prospects; manufacturing and product supply; our efforts to respond to COVID-19, including our COVID-19 products; our expectations regarding the impact of COVID-19 on our business, operations and financial results; and other statements about our business, operations and financial results, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. A description of these risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com.

The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

Category: Finance, Research, Medicines, Vaccines

Media:
[email protected]
+1 (212) 733-1226

Investor:
[email protected]
+1 (212) 733-4848

Source: Pfizer Inc.

Product Pipeline

Learn about specific ways our research is leading to medicines and vaccines that will benefit patients around the world.

Pfizer Quarterly Corporate Performance

Our report for the Second Quarter of 2022.

Product Pipeline

Learn about specific ways our research is leading to medicines and vaccines that will benefit patients around the world.

Product Pipeline

Learn about specific ways our research is leading to medicines and vaccines that will benefit patients around the world.

Analyst Events & Presentations

Check out the latest events and presentations.

Online Counterfeit Medicines

People in the US, and around the globe, are increasingly falling victim to counterfeit drugs sold illegally online.

Coronavirus Resources

Learn about SARS-CoV-2, the coronavirus that causes COVID-19, what you can do to stay safe and prevent the spread, and our scientific efforts to help bring an end to the current global health crisis.

Coronavirus Resources

Learn about SARS-CoV-2, the coronavirus that causes COVID-19, what you can do to stay safe and prevent the spread, and our scientific efforts to help bring an end to the current global health crisis.

Corporate Fact Sheet

For more than 170 years, Pfizer has worked to make a difference for all who rely on us.

Harnessing the Potential of mRNA

Learn more about mRNA technology .

Understanding Six Types of Vaccine Technologies

Ever since the first vaccine was developed in 1796 to treat smallpox,1 several different methods have been created to develop successful vaccines.

Making the COVID-19 Oral Treatment

How 2,000+ Pfizer team members made it happen.

Executive Leadership

Meet the executive leadership team, our senior-most leadership and decision-making management body who focus on major financial, strategic, and operational decisions for the entire company.

Science Hub

With 25,000 clinical researchers testing every day and cutting-edge innovations, our science holds the cure.

Other Vaccine Resources

Vaccines can give your body way to identify an infecting agent, and instructions on how to defeat it—and potentially, avoid infecting others.

Product Hub

Every product is the result of 1,500 scientists overseeing more than 500,000 lab tests and 30+ clinical trials, all before its first prescription.

Lab B-roll Video

Supplemental video of one of our labs.

Vaccines Manufacturing B-roll Video

Supplemental video of manufacturing vaccines.

Paxlovid Manufacturing B-roll Video

Supplemental video of manufacturing Paxlovid.